Cleerly ISCHEMIA vs PMcardio

PMcardio offers a mobile app and web platform, making it highly accessible for clinicians at the point of care, including emergency physicians, GPs, nurses, and paramedics. Cleerly ISCHEMIA is web-based, but its reliance on CCTA scans suggests a more specialized workflow within radiology and cardiology departments. PMcardio's ability to digitize and interpret ECGs from various formats, even old or damaged ones, further enhances its usability in diverse clinical settings.

PMcardio demonstrates broader clinical utility by interpreting ECGs for over 50 cardiac conditions, including critical detections like STEMI/OMI and reduced LVEF, and has been validated in over 25 studies. Cleerly ISCHEMIA focuses specifically on non-invasive ischemia detection from CCTA scans, providing detailed plaque characterization and FFR estimation. While both offer significant value, PMcardio's wider range of detectable conditions from a more commonly available diagnostic tool (ECG) gives it an edge in general clinical applicability.

PMcardio offers a freemium model with a free plan for up to 5 ECG analyses per month, making it accessible for individual clinicians to try and use. Cleerly ISCHEMIA requires contacting them for details, and its pricing varies by provider, suggesting a higher cost and less transparent model for individual users. PMcardio's transparent pricing plans, including individual and team subscriptions, offer clear value propositions.

PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, indicating its readiness for large-scale deployment and integration into existing healthcare infrastructures. Cleerly ISCHEMIA is deployed as a web-based platform with data transfer via Cleerly Proxy (VPN or virtual appliance), which also supports enterprise use, but PMcardio's explicit mention of EHR/CVIS and EMS integrations suggests a more comprehensive approach to enterprise readiness.

PMcardio showcases innovation with its 'Queen of Hearts' STEMI and OMI detection, 'LVsense' for reduced LVEF detection, and 'ECGxplain' for visual AI explainability with heatmaps, providing transparency into its diagnostic process. Cleerly ISCHEMIA's non-invasive FFR estimation and comprehensive plaque characterization from CCTA are also innovative, but PMcardio's explainable AI and broader diagnostic scope from ECGs demonstrate a wider range of innovative features for point-of-care use.

PMcardio provides a Help Center, FAQ, and a Research page with publications, indicating a robust set of support resources and documentation for users. Cleerly ISCHEMIA's information primarily focuses on clinical validation and technical specifications, with less explicit detail on user-facing support and documentation. While both likely offer support, PMcardio's readily available resources suggest a more comprehensive and transparent approach to user assistance.